Global Pediatric Interventional Cardiology Market: by Device Type (Congenital Heart Defect Closure Devices, Transcatheter Heart Valves, Other Device Type), by End Users (Hospitals, Laboratories, Home Healthcare, Other End Users) - Forecast to 2029
Overview
Pediatric Interventional Cardiology Market was valued at US$ 1.79 Bn in 2022 and is expected to reach US$ 3.20 Bn by 2029, at a CAGR of 8.66% during a forecast period.
The report includes the analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.
To know about the Research Methodology :- Request Free Sample Report
Pediatric Interventional Cardiology Market Dynamics
Paediatrics is a branch of medicine that includes the medical care of infants, children, and adolescents. The constant progress of novel minimally invasive devices and the growing population of pediatric patients are boosting the growth of the market during the forecast period. The rising occurrences of congenital heart conditions among paediatric patients, initiatives taken by regulatory authorities to reinforce the interventional cardiology segment, and rising expenses by market applicants for the R&D of novel heart controller products are also propelling the growth of the global paediatric interventional cardiology market.
Pediatric Interventional Cardiology Market Segment Analysis
The complex regulatory procedures are limiting the growth of the market. Closure devices are used to close a fault between the right and left sides of the heart. Some of these birth defects are located between the upper chambers that are atria of the heart.
Transcatheter aortic valve replacement (TAVR) is an invasive procedure to exchange a narrowed aortic valve that fails to open aortic valve stenosis properly. In the TAVR procedure, doctors insert a catheter in a patient’s leg or chest directed towards the heart. Transcatheter aortic valve replacement has some risk factors, which may include bleeding, blood vessel complications, stroke, kidney disease, and heart attack. TAVR improves the lives of people with aortic stenosis whose surgery is too risky and can reduce the risk of death.
Pediatric Interventional Cardiology Market Regional Insights
Europe is estimated for the largest share of the pediatric interventional cardiology market owing to numerous approved interventional cardiology devices present in the European market as well as funds by venture capitalists, and collaborations among the key players in the market. The Asia-Pacific region has significant growth opportunities owing to the high growth in the improving healthcare infrastructure in the region. Moreover, the progress in government investments for improving pediatric care facilities is driving the growth of the region.
The report covers a comprehensive study of major market drivers, restraints, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.
Paediatric Interventional Cardiology Market, Key Highlights:
• Global Paediatric Interventional Cardiology Market analysis and forecast, in terms of value.
• Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Paediatric Interventional Cardiology Market
• Global Paediatric Interventional Cardiology Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.
• Global Paediatric Interventional Cardiology Market strategic analysis with respect to individual growth trends, future prospects along the contribution of various sub-market stakeholders have been considered under the scope of the study.
• Global Paediatric Interventional Cardiology Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.
• Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.
• Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Paediatric Interventional Cardiology Market are also profiled.
Global Pediatric Interventional Cardiology Market Scope: Inquire before buying
| Global Pediatric Interventional Cardiology Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2022 | Forecast Period: | 2023-2029 |
| Historical Data: | 2017 to 2022 | Market Size in 2022: | US $ 1.79 Bn. |
| Forecast Period 2023 to 2029 CAGR: | 8.66% | Market Size in 2029: | US $ 3.20 Bn. |
| Segments Covered: | by Device Type | • Congenital Heart Defect Closure Devices • Transcatheter Heart Valves • Other Device Type |
|
| by End Users | • Hospitals • Laboratories • Home Healthcare • Other End Users |
||
| by Region | • North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America) |
||
Pediatric Interventional Cardiology Market, Key Players are:
• Danaher
• Abbott Laboratories
• Siemens AG
• GENERAL ELECTRIC
• Toshiba Corporation
• Boston Scientific Corporation
• W.L. Gore & Associates, Inc.
• Johnson & Johnson Services, Inc.
• BIOTRONIK
• Koninklijke Philips N.V.
• F. Hoffmann-La Roche Ltd.
• Medtronic
• NuMED, Inc.
• Cook
• PEDIAVASCULAR
• Edwards Lifesciences Corporation
• Agilent Technologies
• Pfm Medical Ag
• Scranton Gillette Communication
Frequently Asked Questions:
1. Which region has the largest share in Global Pediatric Interventional Cardiology Market?
Ans: Europe region holds the highest share in 2022.
2. What is the growth rate of Global Pediatric Interventional Cardiology Market?
Ans: The Global Pediatric Interventional Cardiology Market is growing at a CAGR of 8.66% during forecasting period 2023-2029.
3. What is scope of the Global Pediatric Interventional Cardiology market report?
Ans: Global Pediatric Interventional Cardiology Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Pediatric Interventional Cardiology market?
Ans: The important key players in the Global Pediatric Interventional Cardiology Market are – Danaher, Abbott Laboratories, Siemens AG, GENERAL ELECTRIC, Toshiba Corporation, Boston Scientific Corporation, W.L. Gore & Associates, Inc., Johnson & Johnson Services, Inc., BIOTRONIK, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Medtronic, NuMED, Inc., Cook, PEDIAVASCULAR, Edwards Lifesciences Corporation, Agilent Technologies, Pfm Medical Ag, and Scranton Gillette Communication
5. What is the study period of this market?
Ans: The Global Pediatric Interventional Cardiology Market is studied from 2022 to 2029.